Currently out of the existing stock ratings of Ryan Langston, 40 are a BUY (56.34%), 31 are a HOLD (43.66%).

Ryan Langston

Work Performance Price Targets & Ratings Chart

Analyst Ryan Langston, currently employed at TD COWEN, carries an average stock price target met ratio of 48.01% that have a potential upside of 12.41% achieved within 91 days.

Ryan Langston’s has documented 140 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on DVA, DaVita HealthCare Partners at 07-Aug-2026.

Wall Street Analyst Ryan Langston

Analyst best performing recommendations are on CNC (CENTENE CORP).
The best stock recommendation documented was for EHAB (ENHABIT) at 3/11/2024. The price target of $11 was fulfilled within 4 days with a profit of $1.11 (11.22%) receiving and performance score of 28.06.

Average potential price target upside

ACHC Acadia Healthcare Company ADUS Addus HomeCare AGL agilon health ASTH Astrana Health CNC Centene Corp DVA DaVita HealthCare Partners EHAB Enhabit ELV Elevance Health HCA HCA Holdings HUM Humana PRVA Privia Health Group SGRY Surgery Partners UHS Universal Health Services UNH UnitedHealth Group

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Apr-2025

$39

$9.38 (31.67%)

$38

Hold Since 03-Mar-2026

$32

$2.38 (8.04%)

$25

Buy Since 07-Jan-2025

$36

$6.38 (21.54%)

$30

Buy Since 05-Feb-2025

$40

$10.38 (35.04%)

$25

Buy Since 31-Jul-2023

$39

$9.38 (31.67%)

$31

Show more analysts

Please expand the browser size to see the chart

Which stock is Ryan Langston is most bullish on?

Potential upside of $89.16 has been obtained for ELV (ELEVANCE HEALTH)

Which stock is Ryan Langston is most reserved on?

Potential downside of -$31.83 has been obtained for AGL (AGILON HEALTH)

What Year was the first public recommendation made by Ryan Langston?

On 2023

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?